These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35014603)

  • 21. Generation of orthogonal Fab-based trispecific antibody formats.
    Wu X; Yuan R; Bacica M; Demarest SJ
    Protein Eng Des Sel; 2018 Jul; 31(7-8):249-256. PubMed ID: 29718394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fab-scFv fusion protein: an efficient approach to production of bispecific antibody fragments.
    Lu D; Jimenez X; Zhang H; Bohlen P; Witte L; Zhu Z
    J Immunol Methods; 2002 Sep; 267(2):213-26. PubMed ID: 12165442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding the role of cross-arm binding efficiency in the activity of monoclonal and multispecific therapeutic antibodies.
    Harms BD; Kearns JD; Iadevaia S; Lugovskoy AA
    Methods; 2014 Jan; 65(1):95-104. PubMed ID: 23872324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein design of IgG/TCR chimeras for the co-expression of Fab-like moieties within bispecific antibodies.
    Wu X; Sereno AJ; Huang F; Zhang K; Batt M; Fitchett JR; He D; Rick HL; Conner EM; Demarest SJ
    MAbs; 2015; 7(2):364-76. PubMed ID: 25611120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of camelid VHH bispecific constructs via in-cell intein-mediated protein trans-splicing.
    Shibuya Y; Haga N; Asano R; Nakazawa H; Hattori T; Takeda D; Sugiyama A; Kurotani R; Kumagai I; Umetsu M; Makabe K
    Protein Eng Des Sel; 2017 Jan; 30(1):15-21. PubMed ID: 27881685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EFab domain substitution as a solution to the light-chain pairing problem of bispecific antibodies.
    Cooke HA; Arndt J; Quan C; Shapiro RI; Wen D; Foley S; Vecchi MM; Preyer M
    MAbs; 2018; 10(8):1248-1259. PubMed ID: 30215570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic mechanism of controlled Fab-arm exchange for the formation of bispecific immunoglobulin G1 antibodies.
    Goulet DR; Orcutt SJ; Zwolak A; Rispens T; Labrijn AF; de Jong RN; Atkins WM; Chiu ML
    J Biol Chem; 2018 Jan; 293(2):651-661. PubMed ID: 29150443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NKp46-specific single domain antibodies enable facile engineering of various potent NK cell engager formats.
    Lipinski B; Arras P; Pekar L; Klewinghaus D; Boje AS; Krah S; Zimmermann J; Klausz K; Peipp M; Siegmund V; Evers A; Zielonka S
    Protein Sci; 2023 Mar; 32(3):e4593. PubMed ID: 36775946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Species-specific determinants in the IgG CH3 domain enable Fab-arm exchange by affecting the noncovalent CH3-CH3 interaction strength.
    Labrijn AF; Rispens T; Meesters J; Rose RJ; den Bleker TH; Loverix S; van den Bremer ET; Neijssen J; Vink T; Lasters I; Aalberse RC; Heck AJ; van de Winkel JG; Schuurman J; Parren PW
    J Immunol; 2011 Sep; 187(6):3238-46. PubMed ID: 21841137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Greatest Hits-Innovative Technologies for High Throughput Identification of Bispecific Antibodies.
    Hofmann T; Krah S; Sellmann C; Zielonka S; Doerner A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of a Trispecific Checkpoint Inhibitor and Natural Killer Cell Engager Based on a 2 + 1 Common Light Chain Antibody Architecture.
    Bogen JP; Carrara SC; Fiebig D; Grzeschik J; Hock B; Kolmar H
    Front Immunol; 2021; 12():669496. PubMed ID: 34040611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trispecific F(ab')3 derivatives that use cooperative signaling via the TCR/CD3 complex and CD2 to activate and redirect resting cytotoxic T cells.
    Tutt A; Stevenson GT; Glennie MJ
    J Immunol; 1991 Jul; 147(1):60-9. PubMed ID: 1675655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient heterodimerization of recombinant bi- and trispecific antibodies.
    Schoonjans R; Willems A; Grooten J; Mertens N
    Bioseparation; 2000; 9(3):179-83. PubMed ID: 11105248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Generic Approach for Miniaturized Unbiased High-Throughput Screens of Bispecific Antibodies and Biparatopic Antibody-Drug Conjugates.
    Barron N; Dickgiesser S; Fleischer M; Bachmann AN; Klewinghaus D; Hannewald J; Ciesielski E; Kusters I; Hammann T; Krause V; Fuchs SW; Siegmund V; Gross AW; Mueller-Pompalla D; Krah S; Zielonka S; Doerner A
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fab chains as an efficient heterodimerization scaffold for the production of recombinant bispecific and trispecific antibody derivatives.
    Schoonjans R; Willems A; Schoonooghe S; Fiers W; Grooten J; Mertens N
    J Immunol; 2000 Dec; 165(12):7050-7. PubMed ID: 11120833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elucidating heavy/light chain pairing preferences to facilitate the assembly of bispecific IgG in single cells.
    Joshi KK; Phung W; Han G; Yin Y; Kim I; Sandoval W; Carter PJ
    MAbs; 2019 Oct; 11(7):1254-1265. PubMed ID: 31286843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "BIClonals": Production of Bispecific Antibodies in IgG Format in Transiently Transfected Mammalian Cells.
    Litvak-Greenfeld D; Vaks L; Dror S; Nahary L; Benhar I
    Methods Mol Biol; 2019; 1904():431-454. PubMed ID: 30539485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An expanded genetic code facilitates antibody chemical conjugation involving the lambda light chain.
    Kato A; Ohtake K; Tanaka Y; Yokoyama S; Sakamoto K; Shiraishi Y
    Biochem Biophys Res Commun; 2021 Mar; 546():35-39. PubMed ID: 33561746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rational design and generation of recombinant control reagents for bispecific antibodies through CDR mutagenesis.
    Choi BD; Gedeon PC; Kuan CT; Sanchez-Perez L; Archer GE; Bigner DD; Sampson JH
    J Immunol Methods; 2013 Sep; 395(1-2):14-20. PubMed ID: 23806556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production and characterization of bispecific single-chain antibody fragments.
    De Jonge J; Brissinck J; Heirman C; Demanet C; Leo O; Moser M; Thielemans K
    Mol Immunol; 1995 Dec; 32(17-18):1405-12. PubMed ID: 8643110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.